AYR.A AYR WELLNESS INC

AYR Wellness to Hold Fourth Quarter and Full Year 2023 Conference Call on March 13 at 8:30 a.m. ET

AYR Wellness to Hold Fourth Quarter and Full Year 2023 Conference Call on March 13 at 8:30 a.m. ET

MIAMI, Feb. 08, 2024 (GLOBE NEWSWIRE) -- . (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, will hold a conference call on Wednesday, March 13, 2024, at 8:30 a.m. ET to discuss its results for the fourth quarter and full year ended December 31, 2023.

AYR President & CEO David Goubert and CFO Brad Asher will host the conference call, followed by a question-and-answer period. The Company will provide its financial results in a press release prior to the call.

Date: Wednesday, March 13, 2024

Time: 8:30 a.m. ET

Toll-free dial-in number: (800) 319-4610

International dial-in number: (604) 638-5340

Conference ID: 10023064

Webcast:

A telephonic replay of the conference call will also be available for one month until end of day Saturday, April 13, 2024.

Toll-free replay number: (855) 669-9658

International replay number: (412) 317-0088

Replay ID: 0710

Please dial into the conference call 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact the company’s investor relations team at .

About AYR Wellness Inc.

AYR Wellness is a vertically integrated, U.S. multi-state cannabis business. The Company operates simultaneously as a retailer with 90+ licensed dispensaries and a house of cannabis CPG brands.

AYR is committed to delivering high-quality cannabis products to its patients and customers while acting as a Force for Good for its team members and the communities that the Company serves. For more information, please visit .

Company Contact:

Jon DeCourcey

Head of Investor Relations

T: (786) 885-0397

Email:

Media Contact:

Robert Vanisko

VP, Public Engagement

T: (786) 885-0397

Email:

Investor Relations Contact:

Sean Mansouri, CFA

Elevate IR

T: (786) 885-0397

Email:



EN
08/02/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AYR WELLNESS INC

 PRESS RELEASE

AYR Announces Entry into Limited Waiver Agreement with Senior Notehold...

AYR Announces Entry into Limited Waiver Agreement with Senior Noteholders MIAMI, June 06, 2025 (GLOBE NEWSWIRE) -- (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces that it has entered into a Limited Waiver Agreement (the “Agreement”) with the holders of a majority of its senior secured notes (the “Majority Holders”).‎ The Agreement provides a temporary waiver of certain events of default under the Company’s senior note documents, including those arising from the Company’s previously announced delay in fili...

 PRESS RELEASE

AYR Provides Update on Anticipated Cease Trade Order

AYR Provides Update on Anticipated Cease Trade Order MIAMI, June 06, 2025 (GLOBE NEWSWIRE) -- (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, today provides an update regarding the status of its securities in connection with its previously announced delay in filing its interim financial statements for the quarter ended March 31, 2025.‎ As disclosed on May 30, 2025, the Company was unable to meet the deadline to file its interim financial report, management’s discussion and analysis, and related CEO and CFO certific...

 PRESS RELEASE

AYR Announces Delay of Q1 2024 Financial Statements and MD&A, Expected...

AYR Announces Delay of Q1 2024 Financial Statements and MD&A, Expected Cease Trade Order and Strategic Review Process MIAMI, May 30, 2025 (GLOBE NEWSWIRE) -- (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces that it will be unable to meet the deadline of May 30, 2025 (the “Filing Deadline”) to file its interim financial report and accompanying management’s discussion and analysis and related CEO and ‎CFO certificates for the three month period ended March 31, 2025 (collectively, the “Interim Filings”) as ‎re...

 PRESS RELEASE

Aja Health and Wellness Inc. Provides Update on Delay in Filing Annual...

Aja Health and Wellness Inc. Provides Update on Delay in Filing Annual Financial Statements Not for dissemination in the United States of America VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:AJA) announces that it is getting closer to filing its annual audited financial statements for the financial year ending December 31, 2024, including the related management’s discussion and analysis and certifications from the CEO and CFO (the "Required Annual Filings"). This is an update from the Company's April 29, 202...

 PRESS RELEASE

Aja Health and Wellness Inc. Announces Update on Application for Manag...

Aja Health and Wellness Inc. Announces Update on Application for Management Cease Trade Order Not for dissemination in the United States of America VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that further to its April 17, 2025 news release, it has filed an amended application to the Alberta Securities Commission (the "ASC") seeking a management cease trade order (the "MCTO") under National Policy 12-203 - Management Cease Trade Orders. Aja has made an application seeking a MCTO from the ASC be...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch